NDA 019869 · Otsuka Icu Medcl
Sterile Water For Injection In Plastic Container
Sterile Water For Injection · N/A
Last checked: Nov 19, 2026Latest source record: May 20, 2003 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1989
Dec 26, 1989
Approved uses
1
Original approval plus efficacy supplements
Registered trials
555
138 Phase 3, 52 recruiting
FAERS reports
5,062
2,859 serious, 180 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
Boxed warning
Pharmacy Bulk Package — Not for Direct Infusion. FOR USE ONLY WITH AUTOMATED COMPOUNDING DEVICES.
What it is approved for
From the label in effect Oct 29, 2025.
INDICATIONS AND USAGE Sterile Water for Injection, USP in the Pharmacy Bulk Package is indicated for use with automated compounding devices for preparing intravenous admixtures in the pharmacy.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Dec 26, 1989 Original approval · Type 5 - New Formulation or New Manufacturer
1 products under this application
- STERILE WATER FOR INJECTION IN PLASTIC CONTAINER · STERILE WATER FOR INJECTION 100% · LIQUID, N/A · Prescription · TE AP
Clinical trials
Interventional ClinicalTrials.gov studies with "Sterile Water For Injection" as an intervention, any sponsor and status, largest first.
- A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular DiseasePivotal-lookingActive, not recruiting
University of OxfordAcademic, hospital or other
NCT03705234 · 16,124 participants · Start Oct 30, 2018 · Primary completion Oct 2026
Drug: Inclisiran; Placebo · For: Atherosclerotic Cardiovascular Disease
Sites: Boston, Massachusetts; Oxford, United Kingdom
- Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent TuberculosisPivotal-lookingCompleted
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Industry
NCT01979900 · 10,000 participants · Start Oct 2013 · Primary completion Nov 26, 2017
Drug: Vaccae; placebo · For: Tuberculosis
Sites: Hechi, China; Liuzhou, China · 4 sites in all
- Duration of Cardiac Antimicrobial Prophylaxis Outcomes StudyPivotal-lookingRecruiting
Monash UniversityAcademic, hospital or other
NCT05447559 · 9,180 participants (planned) · Start Feb 7, 2023 · Primary completion Dec 2027
Drug: Cefazolin; Water for injection · For: Surgical Site Infection
Sites: Dallas, Texas; Sydney, Australia; Brisbane, Australia · 27 sites in all
- Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in ColombiaPivotal-lookingActive, not recruiting
Universidad Nacional de ColombiaAcademic, hospital or other
NCT06223919 · 8,686 participants (planned) · Start Dec 16, 2023 · Primary completion Aug 20, 2024
Drug: LC16m8 · For: Monkeypox
Sites: Bogotá, Colombia · 3 sites in all
JhpiegoAcademic, hospital or other
NCT01096134 · 8,000 participants · Start Jan 2011 · Primary completion Nov 2012
Drug: HPV Vaccine (Gardasil) · For: Cervical Cancer
Sites: Cebu, Philippines; Quezon, Philippines; Nakhon Si Thammarat, Thailand · 10 sites in all
- Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan AfricaPivotal-lookingRecruiting
Biofabri, S.LIndustry
NCT04975178 · 7,120 participants (planned) · Start Oct 17, 2022 · Primary completion Feb 2029
Drug: MTBVAC; BCG · For: Tuberculosis
Sites: Worcester, South Africa
Hawler Medical UniversityAcademic, hospital or other
NCT01588171 · 7,020 participants · Start May 2012 · Primary completion Oct 2013
Drug: Bemiparin; Enoxaparin · For: Venous Thromboembolic Diseases
Sites: Erbil, Iraq
- Evaluation of Efficacy and Safety of VPM1002 in Comparison to BCG in Prevention of Tb Infection in InfantsPivotal-lookingCompleted
Serum Institute of India Pvt. Ltd.Industry
NCT04351685 · 6,940 participants · Start Nov 9, 2020 · Primary completion Oct 30, 2024
Drug: VPM1002; BCG SII · For: Mycobacterium Tuberculosis Infection
Sites: Lambaréné, Gabon; Nairobi, Kenya; Siaya, Kenya · 12 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- hereditary angioedema584
- fatigue273
- product dose omission issue265
- nausea254
- headache251
- weight increased242
- weight decreased239
- pain228
- inappropriate schedule of product administration217
- pyrexia210
- vomiting195
- dyspnoea188
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 11 |
| 2005 | 12 |
| 2006 | 3 |
| 2007 | 8 |
| 2008 | 7 |
| 2009 | 10 |
| 2010 | 19 |
| 2011 | 11 |
| 2012 | 18 |
| 2013 | 18 |
| 2014 | 112 |
| 2015 | 272 |
| 2016 | 222 |
| 2017 | 204 |
| 2018 | 583 |
| 2019 | 337 |
| 2020 | 209 |
| 2021 | 335 |
| 2022 | 546 |
| 2023 | 420 |
| 2024 | 614 |
| 2025 | 691 |
| 2026 | 400 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Effectiveness and Safety of Sculptra Poly-L-Lactic Acid Injectable Implant in the Correction of Cheek Wrinkles.
Fabi S, Hamilton T, LaTowsky B, et al. · J Drugs Dermatol 2024 · Randomized Controlled Trial
- Caudal epidural anesthesia in mares after bicarbonate addition to a lidocaine-epinephrine combination.
Duarte PC, Paz CFR, Oliveira APL, et al. · Vet Anaesth Analg 2017 · Randomized Controlled Trial
- Postinfusion phlebitis associated with a syringe system versus minibags.
Rapp RP, Powers P, Tolbert V, et al. · Clin Pharm 1986 · Clinical Trial, Comparative Study
- Selective spinal anesthesia for outpatient laparoscopy. I: characteristics of three hypobaric solutions.
Vaghadia H, Viskari D, Mitchell GW, et al. · Can J Anaesth 2001 · Clinical Trial, Evaluation Study
- Infusion phlebitis associated with a programmable syringe-pump system versus gravity-feed minibottles.
Baptista RJ, Driscoll DF, Gallagher JA, et al. · Clin Pharm 1987 · Clinical Trial, Comparative Study
- A Randomized Study on PLLA Using Higher Dilution Volume and Immediate Use Following Reconstitution.
Palm M, Weinkle S, Cho Y, et al. · J Drugs Dermatol 2021 · Randomized Controlled Trial
Sponsor: Otsuka
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.